BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16820996)

  • 21. TNF-alpha/IL-10 ratio and C-reactive protein as markers of the inflammatory response in CAD-prone North Indian patients with acute myocardial infarction.
    Goswami B; Rajappa M; Mallika V; Shukla DK; Kumar S
    Clin Chim Acta; 2009 Oct; 408(1-2):14-8. PubMed ID: 19576194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi.
    Sharma SK; Mishra HK; Sharma H; Goel A; Sreenivas V; Gulati V; Tahir M
    Sleep Med; 2008 Jan; 9(2):149-56. PubMed ID: 17638590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased peripheral circulating inflammatory cells and plasma inflammatory markers in patients with variant angina.
    Li JJ; Zhang YP; Yang P; Zeng HS; Qian XW; Zhang CY; Zhu CG; Li J; Nan JL
    Coron Artery Dis; 2008 Aug; 19(5):293-7. PubMed ID: 18607165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome.
    Aso Y; Wakabayashi S; Nakano T; Yamamoto R; Takebayashi K; Inukai T
    Metabolism; 2006 Aug; 55(8):1014-21. PubMed ID: 16839835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of coronary artery disease in nondiabetic hemodialysis patients: a matched case-control study.
    Zumrutdal A; Baltali M; Micozkadioglu H; Torun D; Sezer S; Ozdemir FN; Haberal M
    Ren Fail; 2007; 29(1):67-71. PubMed ID: 17365912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-3 is elevated in patients with coronary artery disease and predicts restenosis after percutaneous coronary intervention.
    Rudolph T; Schaps KP; Steven D; Koester R; Rudolph V; Berger J; Terres W; Meinertz T; Kaehler J
    Int J Cardiol; 2009 Mar; 132(3):392-7. PubMed ID: 18378332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between Chlamydia pneumoniae seropositivity, inflammation and risk factors for atherosclerosis in patients with severe coronary stenosis.
    Yavuz MT; Yavuz O; Yazici M; Guler S; Ozhan H; Albayrak S; Coskun A
    Scand J Clin Lab Invest; 2006; 66(6):523-34. PubMed ID: 17000560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of interleukin-6 measurement in the diagnosis of acute myocardial infarction in emergency department.
    Ferroni P; Rosa A; Di Franco M; Palmirotta R; Guadagni F; Davì G; Bertazzoni G; Basili S
    Clin Chim Acta; 2007 Jun; 381(2):151-6. PubMed ID: 17408606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of serum IL-6 levels with comprehensive geriatric assessment variables in a population of elderly cancer patients.
    Mantovani G; Madeddu C; Gramignano G; Ferreli L; Massa E; Contu P; Serpe R
    Oncol Rep; 2004 Jan; 11(1):197-206. PubMed ID: 14654926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease.
    Lee WL; Lee WJ; Chen YT; Liu TJ; Liang KW; Ting CT; Huey-Herng Sheu W
    Metabolism; 2006 Aug; 55(8):1029-34. PubMed ID: 16839837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients.
    Kotur-Stevuljevic J; Memon L; Stefanovic A; Spasic S; Spasojevic-Kalimanovska V; Bogavac-Stanojevic N; Kalimanovska-Ostric D; Jelić-Ivanovic Z; Zunic G
    Clin Biochem; 2007 Feb; 40(3-4):181-7. PubMed ID: 17070511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic inflammatory status in patients with coronary artery ectasia.
    Li JJ; Nie SP; Qian XW; Zeng HS; Zhang CY
    Cytokine; 2009 Apr; 46(1):61-4. PubMed ID: 19232498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study.
    Jacobs M; van Greevenbroek MM; van der Kallen CJ; Ferreira I; Blaak EE; Feskens EJ; Jansen EH; Schalkwijk CG; Stehouwer CD
    Eur J Clin Invest; 2009 Jun; 39(6):437-44. PubMed ID: 19397692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-sensitivity C-reactive protein may be an indicator of the development of atherosclerosis in myocardial bridging.
    Duygu H; Zoghi M; Nalbantgil S; Ozerkan F; Cakir C; Ertas F; Yuksek U; Akilli A; Akin M; Ergene O
    Int J Cardiol; 2008 Feb; 124(2):267-70. PubMed ID: 17395309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm.
    Streitner F; Kuschyk J; Veltmann C; Ratay D; Schoene N; Streitner I; Brueckmann M; Schumacher B; Borggrefe M; Wolpert C
    Cytokine; 2009 Sep; 47(3):166-72. PubMed ID: 19604708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay.
    Martins TB; Anderson JL; Muhlestein JB; Horne BD; Carlquist JF; Roberts WL; Carlquist JF
    Am J Clin Pathol; 2006 Jun; 125(6):906-13. PubMed ID: 16690490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma interleukin-6 and tumor necrosis factor-alpha can predict coronary endothelial dysfunction in hypertensive patients.
    Naya M; Tsukamoto T; Morita K; Katoh C; Furumoto T; Fujii S; Tamaki N; Tsutsui H
    Hypertens Res; 2007 Jun; 30(6):541-8. PubMed ID: 17664858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.